(Q77828166)

English

Concomitant cisplatin and radiotherapy in a conventional and modified fractionation schedule in locally advanced head and neck cancer: a randomised phase II EORTC trial

scientific article published on 01 March 2002

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11916549%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Concomitant cisplatin and radiotherapy in a conventional and modified fractionation schedule in locally advanced head and neck cancer: a randomised phase II EORTC trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11916549%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

phase II clinical trial

1 reference

based on heuristic

inferred from title

head and neck cancer

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

advanced head and neck cancer

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

head and neck carcinoma

1 reference

based on heuristic

inferred from title

author name string

H Bartelink

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11916549%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

W Van den Bogaert

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11916549%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

J-C Horiot

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11916549%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

J Jager

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11916549%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

M van Glabbeke

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11916549%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

publication date

1 March 2002

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11916549%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

European Journal of Cancer

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11916549%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

38

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11916549%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11916549%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

667-673

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11916549%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers: results of the EORTC 22851 randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900425-7

7 January 2021

based on heuristic

inferred from DOI database lookup

A radiation therapy oncology group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900425-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small-cell lung cancer: a randomised multicentre trial. CHART Steering Committee

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900425-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: final analysis of a randomized trial of the EORTC cooperative group of radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900425-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Cisplatin and radiation: interaction probabilities and therapeutic possibilities

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900425-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Therapeutic enhancement in mice by clinically relevant dose and fractionation schedules of cis-diamminedichloroplatinum (II) and irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900425-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Radiotherapy combined with low-dose cis-diammine dichloroplatinum (II) (CDDP) in inoperable nonmetastatic non-small cell lung cancer (NSCLC): a randomized three arm phase II study of the EORTC Lung Cancer and Radiotherapy Cooperative Groups

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900425-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900425-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900425-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900425-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Hyperfractionated radiation therapy and concurrent low-dose, daily carboplatin/etoposide with or without weekend carboplatin/etoposide chemotherapy in stage III non-small-cell lung cancer: a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900425-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Radiotherapy by multiple fractions per day (MFD) in head and neck cancer: acute reactions of skin and mucosa

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900425-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Targeted chemoradiation for advanced head and neck cancer: analysis of 213 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900425-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I trial of concurrent tirapazamine, cisplatin, and radiotherapy in patients with advanced head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900425-7

7 January 2021

based on heuristic

inferred from DOI database lookup

The potential of topoisomerase I inhibitors in the treatment of CNS malignancies: report of a synergistic effect between topotecan and radiation

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900425-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Antibodies against cisplatin-modified DNA and cisplatin-modified (di) nucleotides

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900425-7

7 January 2021

based on heuristic

inferred from DOI database lookup

DNA-adduct levels as a predictor of outcome for NSCLC patients receiving daily cisplatin and radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900425-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0959-8049(01)00425-7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11916549%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11916549%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q77828166&oldid=2113558538"